Romuald Bellmann

Has grant

Associate Professor

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Romuald Bellmann is an Associate Professor at Innsbruck Medical University in Austria. His research primarily focuses on pharmacokinetics and antifungal activity, particularly concerning echinocandins and their impact on critically ill patients. Additionally, he investigates the immune responses related to COVID-19, including the effects of viral levels on interleukin-6, and examines renal-replacement therapy in acute kidney injury contexts.

Recent Grants

Grant: Close

Target-Site Pharmacokinetics and -Activity of Echinocandins

Open Date: 2017-01-01

Close Date: 2021-04-30

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Dorothee von Laer

Medical University of Innsbruck

AUSTRIA

View details

Anna Tobiasch

Medical University of Innsbruck

AUSTRIA

View details

Randy Wax

Assistant Professor

University of Toronto

CANADA

View details

Mathias Ströhle

Medical University of Innsbruck

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Romuald Bellmann

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Human Tissue Distribution of Anidulafungin and Micafungin.

Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients.

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial.

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation.

Penetration of echinocandins into wound secretion of critically ill patients.

Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community.

Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.

Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19.

Anidulafungin and Micafungin Concentrations in Cerebrospinal Fluid and in Cerebral Cortex.

Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy.

Collaborators (4)

Dorothee von Laer

Anna Tobiasch

Randy Wax

Mathias Ströhle

Make your next move.